Contents & References of Antimicrobial effect of marjoram plant extract and pistachio outer shell extract on Helicobacter pylori
List:
None
Source:
1. Aminian, K., 1389, Comparison of three-drug, four-drug and two different methods of treatment regimens in the first-line treatment of heat-borne infection according to the Infectious and Heat-borne Disease Specialist Association, 15th year, number 48.
2. Bahadur, A., 1389, Murray's Medical Microbiology, first edition. Tehran: Khosravi Publications in collaboration with Dibaj Publishing, pp. 270-274
3. Bahar, M., [et al.], 2013, determining the relationship between Helicobacter pylori infection and coronary artery diseases, Tehran: Journal of Iran University of Medical Sciences, year 11, number 39
4. Khalilian, A., [et al.], 1390, the effect of Marzangoosh incense in improving the clinical symptoms of chronic rhinosinusitis, Sari: Mazandaran University of Medical Sciences Journal, number 56. Black cumin, fennel and dill on Helicobacter pylori by disc diffusion and flow cytometry method, Hamedan: Scientific Journal of Hamedan University of Medical Sciences and Health Services, number 3
6. Salyers A., White, D., translation by Nowrozi J. and Kargar M., 2013, Molecular mechanism of bacterial pathogenicity, second edition. Jahrom: Islamic Azad University Jahrom branch
7. Shariat, A., [et al.], 2013, investigation of the antibacterial effect of blue nettle and myrtle extract on Salmonella typhi, Pseudomonas aeruginosa and Escherichia coli, Mashhad, Journal of Science and Innovation in Food Technology/Number 4
8. Salehi, M., [et al.], 2018, bacterial evaluation of wild methanolic extract of pistachio shell, scientific-research journal of microbial technology of Islamic Azad University, 3rd volume, 10th issue.
9. Saneyan, H., [et al., 2019, the effect of probiotics in the treatment of Helicobacter pylori infection in children, Isfahan: Isfahan Medical University Magazine, 29th year, number 146
10. Talebi Bazminabadi, A., [et al., 2018, investigation of antibiotic resistance of Helicobacter pylori isolated from patients referred to Tubi Sari Hospital, Sari: Magazine of Mazandaran University of Medical Sciences, number 71. Ghazanfari Amlashi, D., Discovery of Helicobacter pylori, Tehran: Medical History Quarterly, No. 483.
12. Qadeer, M., [et al.]., 1389, comparison of two regimes of furazolidone, amoxicillin, omeprazole with bismuth and without bismuth in the treatment and eradication of Helicobacter pylori infection, Rasht: Digestive and Liver Diseases Research Center, Faculty of Medicine, Gilan University of Medical Sciences.
13. Kargar, M., [et al.], 2013, Epidemiological study of Helicobacter pylori in patients with digestive disorders in Chahar Mahal and Bakhtiari province, Fasa: Journal of Fasa University of Medical Sciences, number 4
14. Levinson V., translated by Arjamand M., Sotoudhnia A., Fethullahi A., 1385, Javatz's summary of medical microbiology, 9th edition. Tehran: Arjmand Publications, 1386, pp. 202-203
15. Nowrozi, J., Generalities of medical bacteriology, second edition. Tehran: Jafari Publications, 1387, pp. 190-194
16. Nazaifi, A., 2018, study of the effect of omeprazole and ciprofloxacin in the treatment of epigastric ulcer and eradication of Helicobacter pylori, Journal of Iran University of Medical Sciences, 8th year, number 25
17. Nourizadeh, A., 1381, investigating the activity of virulence factors in Helicobacter pylori, Israr Medical Sciences Journal, No. 3
18. Nourizadeh, A., 1380, investigation of the cytotoxic effects of the most active virulence factor of Helicobacter pylori, Tehran: Shahid Faculty of Medical Sciences, 4th Congress of Microbiology.
19. Agha-Amiri, K., [et al]., 2001, A novel immunoassay based on monoclonal antibodies for the detection of Helicobacter pylori antigens in human stool, Z Gastroenterol, Vol.39, No.8, P. 555-60
20. Anthony, P M., 2007, Lipopolysaccharide in bacterial chronic infection: Insights from H. pylori lipopolysaccharide and LipidA, International Journal of Medical Microbiology, P.327-335.
21. Ashour, AA., [et al]., 2001, IceA genotypes of Helicobacter pylori strains isolated from Brazilian children and adults, J Clin Microbiol, Vol. 39, No. 5, P. 1746-50.
22. available from: http://molecularmicrobiology.persianblog.ir. 2013
23. Available from: http://www.aftabir.com/articles/view/science_education/agriculture_ fishery/c3c 1162372872 _ pistacia_vera
24.available from: http://www.tebyan-ardebil.ir/description.aspx?id=8119
25. Bani?, M., [et al]., 2012, Extragastric manifestations of Helicobacter pylori infection, Helicobacter, Suppl 1, P. 49–55. [PubMed]
26. Chang, SB ., [et al]., Attempts to enhance the eradication rate of Helicobacter pylori infection, World Journal of Gastroenterology : WJG
27. Czajkowsky, DM., [et al]., 2005, Nejjari of a host anion channel by a Helicobacter pylori pore-forming toxin. C, Amarti A, et al, Prevalence and distribution of Helicobacter py - Biophys J, Vol.89, No. 5, P. 3093-101
28. Dulciene, M. M., [et al]., 1999, Serological and direct diagnosis of Helicobacter pylori in gastric carcinoma: A case-control study, J. Med. Microbiol., Vol. 48, P.501-506.
29. Dunn, BE., [et al]., 1997, Helicobacter pylori, Clin Microbiol Rev, Vol.10, P. 720–41. [PMC free article] [PubMed]
30. Figueiredo, C., [et al]., 2000, Genetic organization and heterogeneity of the iceA locus of Helicobacter pylori, Gene, Vol.246, No. 1-2, P. 59-68.
31. Filipa, F., [et al]., Overview of the phytomedicine approaches against Helicobacter pylori. World Journal of Gastroenterology: WJG
32. Fuccio, L., [et al]., 2008, Treatment of Helicobacter pylori infection, BMJ, Vol. 337, P. 746-50
33. Gasbarrini, A., [et al]., 1998, Vascular and immunological disorders associated with Helicobacter pylori infection, Ital J Gastroenterol Hepatol, vol.30, P.115–118. [PubMed]
34. Georgopoulos, SD., [et al]., 2006, Hypergastrinemia is associated with increased risk of distal colon adenomas, Digestion, Vol.74, P.42-46. [PubMed]
35. Ghalem B., [et al]., 2009, Antimicrobial activity evaluation of the oleoresin oil of Pistacia vera, AJPP, Vol.3, P. 92-96
36. Goossens, H., [et al]., 1992, Evaluation of a commercially available complement fixation test for diagnosis of Helicobacter pylori infection and for follow-up after antimicrobial therapy, J clin Microbiol, Vol. 30, No. 12, P.3230-3.
37. Horrocks, JC., [et al]., 1978, Clinical presentation of patients with "dyspepsia, Detailed symptomatic study of 360 patients, Gut, Vol. 19, P.19.
38. Kikuchi, S., [et al]., 1999, Association between infections with cagA positive for negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research group on prevention of gastric carcinoma among young adults, Am J Gastroenterol, Vol.94, P. 3455-9.
39. Leodolter, [et al]., 2001, Current standards in the diagnosis of Helicobacter pylori infection, Vol.19, P. 116-22.
40. Loy, CT., [et al]. kits for Helicobacter pylori infection? A meta-analysis, Vol. 91, P. 1138-41. 1994, Helicobacter pylori.Am J Gastroenterology, Vol.89,S116–S128. [PubMed]
43. McColl KEL, 2010, Helicobacter pylori infection, New England Journal of Medicine April 29, Vol.362, P. 1597-604.
44. Nagayato T. 1986, Background data to study of advanced gastric cancer, New York: Springer-v erlag.
45. Nakamura RM, 2001, Laboratory tests for the evaluation of Helicobacter pylori infections, J Clin Lab Anal, Vol.15, No.6, P. 301-7
46. Perri, F., [et al]., 2002, Helicobacter pylori antigen stool test and 13C-urea breath test in patients after eradication treatments, Am J GastroenterolNov, Vol. 97, No. 11, P. 2756-62.
47. Peter, M., [et al]., 2012, Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report, Gut, Vol. 61, P.646–664. [PubMed]
48. Rajaei, A., [et al]